Cargando…
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
Non-Hodgkin’s lymphoma (NHL) is a cancer that starts in the lymphatic system. In NHL, the important part of the immune system, a type of white blood cells called lymphocytes become cancerous. NHL subtypes include marginal zone lymphoma, small lymphocytic lymphoma, follicular lymphoma (FL), and lymph...
Autores principales: | Marofi, Faroogh, Rahman, Heshu Sulaiman, Achmad, Muhammad Harun, Sergeevna, Klunko Nataliya, Suksatan, Wanich, Abdelbasset, Walid Kamal, Mikhailova, Maria Vladimirovna, Shomali, Navid, Yazdanifar, Mahboubeh, Hassanzadeh, Ali, Ahmadi, Majid, Motavalli, Roza, Pathak, Yashwant, Izadi, Sepideh, Jarahian, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261235/ https://www.ncbi.nlm.nih.gov/pubmed/34248965 http://dx.doi.org/10.3389/fimmu.2021.681984 |
Ejemplares similares
-
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021) -
Hurdles to breakthrough in CAR T cell therapy of solid tumors
por: Marofi, Faroogh, et al.
Publicado: (2022) -
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
por: Moghadasi, Soudeh, et al.
Publicado: (2021) -
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
por: Marofi, Faroogh, et al.
Publicado: (2021) -
Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
por: Budi, Hendrik Setia, et al.
Publicado: (2022)